Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eritoran for Glucose Metabolism in Insulin Resistant Subjects
NCT02267317Phase 2Terminated
- Sponsor
- UT Health San Antonio
- Start
- Jan 2015
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of eritoran in type 2 diabetes mellitus (T2DM), obesity, sponsored by UT Health San Antonio. Started Jan 2015; status: terminated.
02
Drugs
eritoran
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT02267317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02267317.